Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesBeyond PSA: Utility of novel tumor markers in the setting of elevated PSA
Urologic Oncology: Seminars and Original Investigations, 07/01/09
Lin DW - In a review of the utility of novel tumor markers in the setting of elevated prostate-specific antigen (PSA), this article will first highlight several characteristics of an ideal biomarker, then focus on select emerging biomarkers for detection of prostate cancer (PCa).
Methods- Introduction of prostate-specific antigen (PSA) for PCa screening and detection has been used for over 20 yrs and has dramatically changed the face of PCa.
- Although it is a highly sensitive serum test, its routine use has been the subject of continued controversy owing to its limited specificity.
- Due to this lack of specificity, many have proposed modifications of PSA in an attempt to bolster the performance of this analyte.
- The human genome project and high throughput gene expression profiling has recently yielded several promising molecular biomarkers for PCa detection beyond PSA or PSA modifications.
Related Articles
Clinical relevance of nine transcriptional molecular markers for the diagnosis of head and neck squamous cell carcinoma in tissue and saliva rinse
BMC Cancer, 10/20/09
Relevance Score: 69%
In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer
Journal of Clinical Oncology, 10/30/09
Relevance Score: 67%
Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas
BMC Cancer, 10/21/09
Relevance Score: 67%
Circulating tumor cells in blood of primary breast cancer patients assessed by a novel RT-PCR test kit and comparison to status of bone marrow-disseminated tumor cells
Breast Cancer Research, 10/15/09
Relevance Score: 67%
Diagnostic utility of SALL4 in primary germ cell tumors of the central nervous system: a study of 77 cases
Modern Pathology, 10/13/09
Relevance Score: 67%
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
High DNA Methyltransferase 3B Expression Mediates 5-Aza-Deoxycytidine Hypersensitivity in Testicular Germ Cell Tumors
Cancer Research, 12/18/09
Phase I trial with a combination of docetaxel and 153Sm-lexidronam in patients with castration-resistant metastatic prostate cancer
Urologic Oncology: Seminars and Original Investigations, 12/18/09
Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer
Clinical Cancer Research, 12/18/09
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer
Clinical Cancer Research, 12/18/09
Patient Perceived Effectiveness of a New Male Sling as Treatment for Post-Prostatectomy Incontinence
The Journal of Urology, 12/18/09
Health-related quality of life in men with localized prostate cancer
International Journal of Urology, 12/18/09
Today in Radiology/Diagnostics...keeping you current
Receive free subspecialty "5-minute updates" via email
Retrospective analysis of prostate cancer recurrence potential with tissue metabolomic profiles
The Prostate, 12/18/09
Influence of Cytokine Gene Polymorphisms on Prostate-Specific Antigen Recurrence in Prostate Cancer after Radical Prostatectomy
Urologia Internationalis, 12/18/09
Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence
Medical Oncology, 12/18/09
Article Search
Sponsor